Regulatory effects of mesenchymal stem cells on B1 cells and Tfh cells in children with systemic lupus erythematosus

Zhou SHE, Fei-Feng WU, Jue-Yi MAO, Chuan WEN

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (2) : 242-249.

PDF(953 KB)
HTML
PDF(953 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (2) : 242-249. DOI: 10.7499/j.issn.1008-8830.2506018
EXPERIMENTAL RESEARCH

Regulatory effects of mesenchymal stem cells on B1 cells and Tfh cells in children with systemic lupus erythematosus

Author information +
History +

Abstract

Objective To investigate B1 cell and follicular helper T (Tfh) levels in children with systemic lupus erythematosus (SLE) and to assess whether mesenchymal stem cells (MSCs) regulate peripheral blood B1 cells and Tfh cells in pediatric SLE. Methods Peripheral blood mononuclear cells (PBMCs) were isolated from children with SLE and from controls. B1 and Tfh cells were measured, differences between groups were analyzed, and correlations with clinical indices were evaluated. Human umbilical cord mesenchymal stem cells (hUCMSCs) were co-cultured with PBMCs for 48 hours at hUCMSC:PBMC ratios of 1:10 and 1:20, with PBS-treated PBMCs as control; post-culture proportions of B1 and Tfh cells were re-assessed. Results hUCMSCs adhered to plastic with spindle-shaped morphology, showed robust growth, and exhibited osteogenic and adipogenic differentiation. B1 and Tfh cell levels were higher in children with SLE than in controls (P<0.05) and were not significantly correlated with serum complement, immunoglobulins, antibody levels, or SLE Disease Activity Index scores (P>0.05). Tfh cells showed a trend toward association with serum C4 and IgM. After co-culture, no statistically significant differences in B1 or Tfh cell proportions were detected among the PBS control and hUCMSC co-culture groups (P>0.05). Conclusions B1 cells and Tfh cells differ between children with SLE and controls and may be involved in SLE pathogenesis. hUCMSCs do not appear to exert therapeutic effects in SLE by regulating peripheral blood B1 and Tfh cell numbers.

Key words

Systemic lupus erythematosus / Mesenchymal stem cell / B1 cell / Tfh cell / Child

Cite this article

Download Citations
Zhou SHE , Fei-Feng WU , Jue-Yi MAO , et al. Regulatory effects of mesenchymal stem cells on B1 cells and Tfh cells in children with systemic lupus erythematosus[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(2): 242-249 https://doi.org/10.7499/j.issn.1008-8830.2506018

References

[1]
Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus[J]. Nat Immunol, 2020, 21(6): 605-614. PMCID: PMC8135909. DOI: 10.1038/s41590-020-0677-6 .
[2]
Jin W, Luo Z, Yang H. Peripheral B cell subsets in autoimmune diseases: clinical implications and effects of B cell-targeted therapies[J]. J Immunol Res, 2020, 2020: 9518137. PMCID: PMC7125470. DOI: 10.1155/2020/9518137 .
[3]
Konya C, Paz Z, Tsokos GC. The role of T cells in systemic lupus erythematosus: an update[J]. Curr Opin Rheumatol, 2014, 26(5): 493-501. DOI: 10.1097/BOR.0000000000000082 .
[4]
Sharma J, Hampton JM, Valiente GR, et al. Therapeutic development of mesenchymal stem cells or their extracellular vesicles to inhibit autoimmune-mediated inflammatory processes in systemic lupus erythematosus[J]. Front Immunol, 2017, 8: 526. PMCID: PMC5423896. DOI: 10.3389/fimmu.2017.00526 .
[5]
Ryan JM, Barry FP, Murphy JM, et al. Mesenchymal stem cells avoid allogeneic rejection[J]. J Inflamm (Lond), 2005, 2: 8. PMCID: PMC1215510. DOI: 10.1186/1476-9255-2-8 .
[6]
Xie M, Xiong W, She Z, et al. Immunoregulatory effects of stem cell-derived extracellular vesicles on immune cells[J]. Front Immunol, 2020, 11: 13. PMCID: PMC7026133. DOI: 10.3389/fimmu.2020.00013 .
[7]
Vizoso FJ, Eiro N, Costa L, et al. Mesenchymal stem cells in homeostasis and systemic diseases: hypothesis, evidences, and therapeutic opportunities[J]. Int J Mol Sci, 2019, 20(15): 3738. PMCID: PMC6696100. DOI: 10.3390/ijms20153738 .
[8]
Cras A, Farge D, Carmoi T, et al. Update on mesenchymal stem cell-based therapy in lupus and scleroderma[J]. Arthritis Res Ther, 2015, 17: 301. PMCID: PMC4631077. DOI: 10.1186/s13075-015-0819-7 .
[9]
中国狼疮肾炎诊治和管理指南工作组, 国家肾脏疾病临床医学研究中心. 中国狼疮肾炎诊治和管理指南(2025版)[J]. 中华医学杂志, 2025, 105(22): 1783-1819. DOI: 10.3760/cma.j.cn112137-20250327-00748 .
[10]
中华医学会风湿病学分会, 中国医院协会临床新技术应用专业委员会. 异体间充质干细胞治疗系统性红斑狼疮专家共识[J]. 中华风湿病学杂志, 2022, 26(1): 1-8. DOI: 10.3760/cma.j.cn141217-20210923-00381 .
[11]
白茹, 戚燕, 吕昭萍, 等. 脐带间充质干细胞移植治疗难治性系统性红斑狼疮3年随访[J]. 中国免疫学杂志, 2017, 33(6): 905-909. DOI: 10.3969/j.issn.1000-484X.2017.06.020 .
[12]
Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus[J]. Arthritis Rheum, 2010, 62(8): 2467-2475. DOI: 10.1002/art.27548 .
[13]
Liang J, Zhang H, Hua B, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study[J]. Ann Rheum Dis, 2010, 69(8): 1423-1429. DOI: 10.1136/ard.2009.123463 .
[14]
Tang WY, Liu JH, Peng CJ, et al. Functional characteristics and application of mesenchymal stem cells in systemic lupus erythematosus[J]. Arch Immunol Ther Exp (Warsz), 2021, 69(1): 7. DOI: 10.1007/s00005-021-00603-y .
[15]
Yang C, Sun J, Tian Y, et al. Immunomodulatory effect of MSCs and MSCs-derived extracellular vesicles in systemic lupus erythematosus[J]. Front Immunol, 2021, 12: 714832. PMCID: PMC8481702. DOI: 10.3389/fimmu.2021.714832 .
[16]
Yuan L, Xiao ZT, Huang XZ, et al. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation[J]. Ren Fail, 2016, 38(9): 1432-1440. DOI: 10.3109/0886022X.2015.1136894 .
[17]
Zhou K, Zhang H, Jin O, et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice[J]. Cell Mol Immunol, 2008, 5(6): 417-424. PMCID: PMC4072411. DOI: 10.1038/cmi.2008.52 .
[18]
Nakayamada S, Tanaka Y. Clinical relevance of T follicular helper cells in systemic lupus erythematosus[J]. Expert Rev Clin Immunol, 2021, 17(10): 1143-1150. DOI: 10.1080/1744666X.2021.1976146 .
[19]
Zhang Z, Feng R, Niu L, et al. Human umbilical cord mesenchymal stem cells inhibit T follicular helper cell expansion through the activation of iNOS in lupus-prone B6.MRL- Fas lpr mice[J]. Cell Transplant, 2017, 26(6): 1031-1042. PMCID: PMC5657746. DOI: 10.3727/096368917X694660 .
[20]
Yang X, Yang J, Li X, et al. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice[J]. Lupus, 2018, 27(1): 49-59. DOI: 10.1177/0961203317711013 .
[21]
Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli[J]. Blood, 2002, 99(10): 3838-3843. DOI: 10.1182/blood.v99.10.3838 .
[22]
BARTHOLOMEW A, STURGEON C, SIATSKAS M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J]. Exp Hematol, 2002, 30(1): 42-48. DOI: 10.1016/s0301-472x(01)00769-x .
[23]
Li K, Han Q, Yan X, et al. Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing[J]. Stem Cells Dev, 2010, 19(8): 1267-1275. DOI: 10.1089/scd.2009.0196 .
[24]
Gu Z, Akiyama K, Ma X, et al. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice[J]. Lupus, 2010, 19(13): 1502-1514. DOI: 10.1177/0961203310373782 .
[25]
Wang D, Huang S, Yuan X, et al. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus[J]. Cell Mol Immunol, 2017, 14(5): 423-431. PMCID: PMC5423084. DOI: 10.1038/cmi.2015.89 .
[26]
Che N, Li X, Zhou S, et al. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation[J]. Cell Immunol, 2012, 274(1/2): 46-53. DOI: 10.1016/j.cellimm.2012.02.004 .
[27]
Deng W, Chen W, Zhang Z, et al. Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus[J]. Clin Immunol, 2015, 161(2): 209-216. DOI: 10.1016/j.clim.2015.07.011 .
[28]
梁军, 孙凌云. 间充质干细胞治疗系统性红斑狼疮的基础和临床研究[J]. 浙江医学, 2017, 39(21): 1836-1841. DOI: 10.12056/j.issn.1006-2785.2017.39.21.2017-1690 .
[29]
Wang D, Li J, Zhang Y, et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study[J]. Arthritis Res Ther, 2014, 16(2): R79. PMCID: PMC4060570. DOI: 10.1186/ar4520 .
[30]
Wang D, Zhang H, Liang J, et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience[J]. Cell Transplant, 2013, 22(12): 2267-2277. PMCID: PMC11849135. DOI: 10.3727/096368911X582769c .
[31]
Wang D, Niu L, Feng X, et al. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study[J]. Clin Exp Med, 2017, 17(3): 333-340. DOI: 10.1007/s10238-016-0427-0 .
[32]
Mohan C, Morel L, Yang P, et al. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice[J]. Arthritis Rheum, 1998, 41(9): 1652-1662. DOI: 10.1002/1529-0131(199809)41:9<1652::AID-ART17>3.0.CO;2-W .
[33]
Murakami M, Yoshioka H, Shirai T, et al. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells[J]. Int Immunol, 1995, 7(5): 877-882. DOI: 10.1093/intimm/7.5.877 .
[34]
Xu Z, Potula HH, Vallurupalli A, et al. Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1[J]. J Immunol, 2011, 186(12): 6673-6682. PMCID: PMC3774832. DOI: 10.4049/jimmunol.1002544 .
[35]
She Z, Li C, Wu F, et al. The role of B1 cells in systemic lupus erythematosus[J]. Front Immunol, 2022, 13: 814857. PMCID: PMC8995743. DOI: 10.3389/fimmu.2022.814857 .
[36]
Moreth K, Brodbeck R, Babelova A, et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis[J]. J Clin Invest, 2010, 120(12): 4251-4272. PMCID: PMC2993585. DOI: 10.1172/JCI42213 .
[37]
Sato T, Ishikawa S, Akadegawa K, et al. Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus[J]. Eur J Immunol, 2004, 34(12): 3346-3358. DOI: 10.1002/eji.200425373 .
[38]
Ma K, Du W, Wang S, et al. B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation[J]. Cell Mol Immunol, 2023, 20(8): 881-894. PMCID: PMC10250184. DOI: 10.1038/s41423-023-01049-2 .
[39]
Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70- [J]. J Exp Med, 2011, 208(1): 67-80. PMCID: PMC3023138. DOI: 10.1084/jem.20101499 .
[40]
Kraljevic K, Wong S, Fulcher DA. Circulating phenotypic B-1 cells are decreased in common variable immunodeficiency and correlate with immunoglobulin M levels[J]. Clin Exp Immunol, 2013, 171(3): 278-282. PMCID: PMC3569535. DOI: 10.1111/cei.12008 .
[41]
Tørring C, Petersen CC, Bjerg L, et al. The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis[J]. J Neuroimmunol, 2013, 262(1/2): 92-99. DOI: 10.1016/j.jneuroim.2013.06.002 .
[42]
Quách TD, Rodríguez-Zhurbenko N, Hopkins TJ, et al. Distinctions among circulating antibody-secreting cell populations, including B-1 cells, in human adult peripheral blood[J]. J Immunol, 2016, 196(3): 1060-1069. PMCID: PMC5351554. DOI: 10.4049/jimmunol.1501843 .
[43]
Rodriguez-Zhurbenko N, Quach TD, Hopkins TJ, et al. Human B-1 cells and B-1 cell antibodies change with advancing age[J]. Front Immunol, 2019, 10: 483. PMCID: PMC6433875. DOI: 10.3389/fimmu.2019.00483 .
[44]
陈俊伟, 景晓娜, 郝美华, 等. 系统性红斑狼疮患者CD5+B细胞的变化及其意义[J]. 中华风湿病学杂志, 2017, 21(8): 513-517, 后插1. DOI: 10.3760/cma.j.issn.1007-7480.2017.08.003 .
[45]
Linterman MA, Rigby RJ, Wong RK, et al. Follicular helper T cells are required for systemic autoimmunity[J]. J Exp Med, 2009, 206(3): 561-576. PMCID: PMC2699132. DOI: 10.1084/jem.20081886 .
[46]
Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity[J]. Nature, 2005, 435(7041): 452-458. DOI: 10.1038/nature03555 .
[47]
Liarski VM, Kaverina N, Chang A, et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue[J]. Sci Transl Med, 2014, 6(230): 230ra46. PMCID: PMC4129446. DOI: 10.1126/scitranslmed.3008146 .
[48]
Choi JY, Ho JH, Pasoto SG, et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity[J]. Arthritis Rheumatol, 2015, 67(4): 988-999. PMCID: PMC4450082. DOI: 10.1002/art.39020 .
[49]
Jang E, Jeong M, Kim S, et al. Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development[J]. Cell Transplant, 2016, 25(1): 1-15. DOI: 10.3727/096368915X688173 .

Footnotes

所有作者声明无利益冲突。

PDF(953 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/